| Bibliografie - Referinte Fosfatidilcolina |
|
| Informatii din bibliografia electronica la tema: Nutritie si sanatate |
3. Barbeau A. Emerging treatments: replacement therapy with choline or lecithin
in neurological diseases. Canadian Journal of Neurological Sciences. 1978;5(1):157-160.
- Pomara N, Domino EF, Yoon H, Brinkman S, Tamminga CA, Gershon S. Failure of
single-dose lecithin to alter aspects of central cholinergic activity in Alzheimer's
disease. Journal of Clinical Psychiatry. 1983;44(8):293-295.
- Barbeau A. Lecithin in Parkinson's disease. Journal of Neural Transmission
Supplement. 1980;(16):187-193.
4. Little A, Levy R, Chuaqui-Kidd P, Hand D. A double-blind, placebo controlled
trial of high-dose lecithin in Alzheimer's disease. Journal of Neurology, Neurosurgery,
and Psychiatry. 1985;48(8):736-742.
- Perryman KM, Fitten LJ. Delayed matching-to-sample performance during a double-blind
trial of tacrine (THA) and lecithin in patients with Alzheimer's disease. Life
Science. 1993;53(6):479-486.
- Maltby N, Broe GA, Creasey H, Jorm AF, Christensen H, Brooks WS. Efficacy of
tacrine and lecithin in mild to moderate Alzheimer's disease: double-blind trial.
British Medical Journal 1994;308(6933):879-883.
5. Fitten LJ, Perryman KM, Gross PL, Fine H, Cummins J, Marshall C. Treatment
of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind
study. American Journal of Psychiatry. 1990;147(2):239-242.
6. Brinkman SD, Smith RC, Meyer JS, et al. Lecithin and memory training in suspected
Alzheimer's disease. Journal of Gerontology. 1982;37(1):4-9.
7. The effect of long-term high dose lecithin on erythrocyte choline transport
in Alzheimer patients. Uney JB, Jones GM, Rebeiro A, Levy R Biol Psychiatry 1992
Mar 15 31:6 630-3
Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate